BGM0504
A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 120
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| 5 mg BGM0504 | n/r | n/r | n/r | n/r |
| 10 mg BGM0504 | n/r | n/r | n/r | n/r |
| 15 mg BGM0504 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- 5 mg BGM0504: endpoint not reported
- 10 mg BGM0504: endpoint not reported
- 15 mg BGM0504: endpoint not reported
- Placebo: endpoint not reported